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Abstract
Urachal adenocarcinoma is a rare tumor and represents 0.17–0.34% of all bladder tumors. It has
an insidious course and variable clinical presentation. We present a case report of a 58 year old
white male with an urachal cyst who suffered irritative voiding symptoms and long term mucusuria,
since childhood. After surgical removal of the cyst with a partial cystectomy a mucus
adenocarcinoma was diagnosed histologically.
The patient after a negative for metastatic disease screen underwent a completion radical
cystectomy with pelvic lymph node clearance. Clinicians should have a high degree of suspicion for
these rare tumors.
Background
Adenocarcinoma of the urachus arises from the urachal
remnant. It is a rare and devastating disease, representing
0.17–0.34% of all bladder tumors [1,2]. It is believed that
arises from malignant transformation of columnar or
glandular metaplastic epithelium. Clinically the distinc-
tion of urachal carcinoma from other bladder adenocarci-
nomas may be difficult especially if the tumor is locally
extensive. Histological types include mucinous, enteric,
unspecified, signet ring-cell, and mixed variants [3]. In
this case report we present a 58 year old white male with
a long lasting history of mucusuria, recurrent bacteriuria
and lower urinary tract symptoms which finally revealed
urachal adenocarcinoma. Also a short review of the litera-
ture is presented.
Case report
A 58 year old white male presented in our department
with mucusuria, recurrent bacteriuria and lower urinary
tract symptoms. He had been treated in the past for recur-
rent episodes of prostatitis. He also reported mucusuria
that had been present since childhood and for that reason
thought it was not unusual. He did not report any hema-
turia. Abdominal examination revealed a round, smooth,
firm, non-tender, suprapubic mass. The prostate gland
was soft, painless and of normal size. Biochemical and
haematological analysis was normal. An abdominal com-
puterised tomography (CT scan) revealed a 7 × 6 cm
round supravesical, midline cyst, with extension into the
bladder (figure 1). Antegrade cystography did not reveal
any communication between the bladder and the cyst.
Rigid cystoscopy under general anaesthesia showed a
round and smooth protrusion at the level of the dome
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and presence of an orifice. The cyst was filled with mucous
and there were multiple papillary lesions on the inner sur-
face of the cyst that was biopsied. Histology revealed a
urachal adenoma, with no signs of malignancy. The
patient underwent an open transperitoneal removal of the
cyst (figure 2) and partial cystectomy. Histological exami-
nation of the specimen revealed an invasive mucus aden-
ocarcinoma with positive surgical margins. The patient
was further evaluated with a pulmonary CT and bone scan
which were both negative for metastatic disease. Subse-
quently he underwent a radical cystectomy and pelvic
lymph node dissection with orthotopic neobladder con-
struction.
Discussion
Most cases of urachal adenocarcinomas occur in the fifth
and sixth decade of life. Clinical presentation varies.
Hematuria is encountered in more that two thirds of
cases. Less common symptoms are mucusuria, lower uri-
nary tract symptoms and a palpable suprapubic mass
[4,5]. Mucusuria presents in a 25% of the cases and merits
special attention as it may be overlooked for an extremely
long time before the correct diagnosis. The most common
reason is confusion with lower urinary tract infections
such as urethritis and chronic prostatitis.
If after a trial of antibiotic therapy symptoms do not
resolve, a full urologic workup with cystoscopy and
abdominal ultrasound or CT scan is indicated. CT appear-
ance is of a large mixed solid and cystic lesion with the
bulk of the tumor outside the bladder. Extravesical spread
is common. In relation to the urinary bladder wall urachal
carcinomas may be intramucosal, intramuscular or
supravesival, (behind the anterior abdominal wall in the
midline) [6]. Tumor calcification is based on mucus pro-
duction that is encountered in 72%. When present it sug-
gests a urachal adenocarcinoma and it is usually located at
the edge of the tumor and it is patchy rather than contin-
uous [2,7].
Treatment consists of open radical or partial cystectomy
with pelvic lymph node dissection, and excision of the
umbilicus and the urachal ligament [1,2]. Laparoscopic
partial cystectomy with lymphadenectomy has been
reported as an alternative treatment but long term follow
up is required in order to determine the oncologic effect
of this treatment [8]. In a recent study from Mayo clinic,
staging with TNM system was the main predictor of out-
come after surgery for urachal adenocarcinoma [9]. Also
negative margin status has been identified as an impor-
tant factor for long term-survival and adequate local treat-
ment is of paramount value [9,10]. Prognosis does not
appear to be significantly influenced by histology and
grade of the tumor. Metastatic disease has a poor response
to chemotherapy but some tumors may respond to cispl-
atin based regimens. Overall survival for all stages is 62
months with a 34% of the patients still alive after 5 years.
Conclusion
Misdiagnosis of urachal carcinoma is still a reality. Accu-
rate diagnosis necessitates a degree of suspicion and
appropriate imaging studies. Appropriate local treatment
is the key for improved survival.
Consent
Written informed consent was obtained from the patient
for publication of this case report and accompanying
images. A copy of the written consent is available for
review by the Editor-in-Chief of this journal.
Contrast-enhanced CT scan at level of iliac crests shows a  low attenuation cyst overlying the anterosuperior portion of  bladder with focal calcifications Figure 1
Contrast-enhanced CT scan at level of iliac crests 
shows a low attenuation cyst overlying the anterosu-
perior portion of bladder with focal calcifications.
Intraoperative findings of cystic lesion at the dome of the  bladder Figure 2
Intraoperative findings of cystic lesion at the dome of 
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